Someili, Ali and Abu Hilal, Mohannad and Azzam, Khalid (2019) Linagliptin-Associated Alopecia and Bullous Pemphigoid. European Journal of Case Reports in Internal Medicine, 6 (9). ISSN 2284-2594
|
Text
document(1).pdf - Published Version Download (678kB) | Preview |
Abstract
Bullous pemphigoid is a chronic autoimmune blistering disease. Recently, several reports suggested dipeptidyl peptidase 4 (DPP-4) inhibitors, also known as gliptins, were a potential cause of drug-induced bullous pemphigoid but not of both bullous pemphigoid and alopecia areata together. Here we describe the case of a 68-year-old man with type 2 diabetes mellitus who developed new onset diffuse alopecia on the scalp with diffuse tense bullae over his body a few months after linagliptin was introduced for better control of his diabetes. DPP-4 inhibitors are not known to increase the risk of alopecia. To the best of our knowledge, this is the first report of linagliptin-associated alopecia areata and bullous pemphigoid, which may help demonstrate if there are any links between DPP-4 inhibitors and alopecia.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Gliptin, drug, bullous pemphigoid |
| Subjects: | 600 Tecnologia - Scienze applicate > 610 Medicina e salute (Classificare qui la tecnologia dei servizi medici) > 616 Malattie (classificare qui la Clinica medica, la medicina basata sull'evidenza, la Medicina interna, la Medicina sperimentale) |
| Depositing User: | Chiara D'Arpa |
| Date Deposited: | 18 Nov 2020 20:50 |
| Last Modified: | 18 Nov 2020 20:50 |
| URI: | http://eprints.bice.rm.cnr.it/id/eprint/19517 |
Actions (login required)
 |
View Item |
